Access Resources
891 - 900 of 7616 Results
Title
Year
-
RESTRICTEDTitle: Nano drug delivery systems for antisense oligonucleotides (ASO) therapeuticsJournal Name: Journal of Controlled ReleasePublisher: Elsevier BVVol: 352Issue #:Start Page: 861End Page: 878Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jconrel.2022.10.050Citation Count: 22
-
RESTRICTEDTitle: Non-REM sleep with hypertonia in Parkinsonian Spectrum Disorders: A pilot investigationJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 100Issue #:Start Page: 501End Page: 510Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.sleep.2022.09.025Best OA location URL: https://doi.org/10.1016/j.sleep.2022.09.025Citation Count: 5
-
RESTRICTEDTitle: Orchestration of selective autophagy by cargo receptorsJournal Name: Current BiologyPublisher: Elsevier BVVol: 32Issue #: 24Start Page: R1357End Page: R1371Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.cub.2022.11.002Best OA location URL: https://doi.org/10.1016/j.cub.2022.11.002Citation Count: 32
-
RESTRICTEDTitle: P5B-ATPases in the mammalian polyamine transport system and their role in diseaseJournal Name: Biochimica et Biophysica Acta (BBA) - Molecular Cell ResearchPublisher: Elsevier BVVol: 1869Issue #: 12Start Page: 119354End Page: 119354Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oa, publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.bbamcr.2022.119354Best OA location URL: https://doi.org/10.1016/j.bbamcr.2022.119354Citation Count: 11
-
RESTRICTEDTitle: Parkinson’s disease drug hunters think outside the α-synuclein boxJournal Name: Nature BiotechnologyPublisher: Springer Science and Business Media LLCVol: 40Issue #: 12Start Page: 1705End Page: 1707Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41587-022-01610-wCitation Count: 1
- Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s disease2022RESTRICTEDTitle: Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s diseaseJournal Name: Biomedicine & PharmacotherapyPublisher: Elsevier BVVol: 156Issue #:Start Page: 113908End Page: 113908Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.biopha.2022.113908Best OA location URL: https://doi.org/10.1016/j.biopha.2022.113908Citation Count: 3
-
RESTRICTEDTitle: Pompe disease treated before birthJournal Name: Nature BiotechnologyPublisher: Springer Science and Business Media LLCVol: 40Issue #: 12Start Page: 1707End Page: 1707Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41587-022-01621-7Citation Count: 0
-
RESTRICTEDTitle: Precision medicine for Parkinson’s disease: The subtyping challengeJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.1064057Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.1064057/pdfCitation Count: 2
- REM sleep behavior and olfactory dysfunction: Enhancing the utility and translation of animal models in the search for precision medicines for Parkinson's disease2022RESTRICTEDTitle: REM sleep behavior and olfactory dysfunction: Enhancing the utility and translation of animal models in the search for precision medicines for Parkinson's diseaseJournal Name: Neuroscience & Biobehavioral ReviewsPublisher: Elsevier BVVol: 143Issue #:Start Page: 104897End Page: 104897Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neubiorev.2022.104897Citation Count: 1
- Renin-angiotensin system blockers affect cognitive decline in Parkinson's disease: The PPMI dataset2022RESTRICTEDTitle: Renin-angiotensin system blockers affect cognitive decline in Parkinson's disease: The PPMI datasetJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 105Issue #:Start Page: 90End Page: 95Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.019Citation Count: 7